Epilepsy and demyelination: Towards a bidirectional relationship

Prog Neurobiol. 2024 Mar:234:102588. doi: 10.1016/j.pneurobio.2024.102588. Epub 2024 Feb 18.

Abstract

Demyelination stands out as a prominent feature in individuals with specific types of epilepsy. Concurrently, individuals with demyelinating diseases, such as multiple sclerosis (MS) are at a greater risk of developing epilepsy compared to non-MS individuals. These bidirectional connections raise the question of whether both pathological conditions share common pathogenic mechanisms. This review focuses on the reciprocal relationship between epilepsy and demyelination diseases. We commence with an overview of the neurological basis of epilepsy and demyelination diseases, followed by an exploration of how our comprehension of these two disorders has evolved in tandem. Additionally, we discuss the potential pathogenic mechanisms contributing to the interactive relationship between these two diseases. A more nuanced understanding of the interplay between epilepsy and demyelination diseases has the potential to unveiling the molecular intricacies of their pathological relationships, paving the way for innovative directions in future clinical management and treatment strategies for these diseases.

Keywords: Demyelination; Epilepsy; Glia; Inflammation; Multiple sclerosis.

Publication types

  • Review

MeSH terms

  • Demyelinating Diseases* / pathology
  • Epilepsy* / complications
  • Humans
  • Multiple Sclerosis* / complications
  • Multiple Sclerosis* / pathology